Degarelix

FirmagonSexual Health

Evidence grade

AFDA-approved Rx (labeled use)

Cardiovascular · 0–5 · separate axis

Read first · not dosing instructions

Educational and research reference only. Not medical advice, not a recommendation, and not dosing instructions for any person. Figures are reported from the cited source and may be wrong or out of date. Research peptides are not approved for human use. Adults 18+. Consult a licensed physician before any decision about your health.

PurposeReproductive axis

MechanismGnRH receptor antagonist; suppresses testosterone immediately with no initial flare

EffectsBlocks the receptor directly, avoiding the testosterone surge that agonists cause

Dosing240 mg SC loading dose, then 80 mg SC every 28 days

Bottom lineStrongest data when used for its labeled indication under clinician guidance.

Batches on filenone

No tested batches on file.

Read with10

Oxytocin ANP (Atrial natriuretic peptide)BNP (B-type natriuretic peptide)Apelin Adrenomedullin Vasopressin Bivalirudin Eptifibatide Melanotan II Semaglutide

Cautions & interactions

Injection-site reactions are common; hot flushes; transaminase elevations

Additive with other hormone therapies; may prolong QT.

CV 2 of 5 — Some comparative data suggest fewer cardiovascular events than GnRH agonists in men with existing cardiac disease.